SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Illumina (ILMN) Optics for Genomics
ILMN 121.07-1.1%Nov 6 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Elmer who started this subject1/29/2002 7:06:05 PM
From: mopgcw  Read Replies (1) of 276
 
Illumina Signs Genotyping Services Agreement With Investigators At Boston University Medical Center

SNP Scoring Service to Leverage Illumina's BeadArray Platform Technology

SAN DIEGO--(BW HealthWire)--Jan. 28, 2002--Illumina, Inc. announced today that it has signed a commercial agreement with investigators at Boston University Medical Center to provide single nucleotide polymorphism (SNP) genotyping services for a large-scale research project on preterm birth. Under the terms of the agreement, Illumina will use its BeadArray(TM) technology to ``score'' a set of SNPs thought to be associated with preterm birth. Illumina will also design SNP assays for the SNP loci provided by the investigators. Further details about the agreement were not disclosed.

``We are pleased that investigators at Boston University Medical Center have decided to leverage the power and cost-effectiveness of our BeadArray(TM) technology,'' stated Jay Flatley, Illumina President and CEO. ``Investigators at Boston University Medical Center are conducting leading-edge research to understand environmental and genetic determinants of preterm birth, which is the leading cause of infant mortality and morbidity,'' continued Flatley.

``We look forward to continued collaborations with investigators at Boston University Medical Center and other organizations to speed the analysis and lower the cost of genotyping.''
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News